Advanced Biomed Inc.
ADVB
$0.60
$0.1431.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 97.44% | 18.62% | -39.01% | 24.79% | -6.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.08% | 2.32% | -19.28% | 18.13% | -30.87% |
| Operating Income | -72.08% | -2.32% | 19.28% | -18.13% | 30.87% |
| Income Before Tax | 13.32% | -31.03% | -524.85% | 65.56% | 51.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.32% | -31.03% | -524.85% | 65.56% | 51.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.32% | -31.03% | -524.85% | 65.56% | 51.84% |
| EBIT | -72.08% | -2.32% | 19.28% | -18.13% | 30.87% |
| EBITDA | -108.48% | -3.35% | 26.16% | -19.07% | 44.29% |
| EPS Basic | 20.00% | -28.03% | -521.92% | 65.54% | 52.01% |
| Normalized Basic EPS | 19.76% | -27.88% | -531.11% | 65.56% | 52.08% |
| EPS Diluted | 20.00% | -28.03% | -521.92% | 65.54% | 52.01% |
| Normalized Diluted EPS | 19.76% | -27.88% | -531.11% | 65.56% | 52.08% |
| Average Basic Shares Outstanding | 8.17% | 2.40% | 0.00% | 0.00% | 0.45% |
| Average Diluted Shares Outstanding | 8.17% | 2.40% | 0.00% | 0.00% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |